Join Matindale-Hubbell Connected



Search Results (2760)

  
Documents on biotech life sciences
 

View Page: <<  Prev  11  12  13  14  15  16  17  18  19  20  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLOSHA Issues Brochure on Safe Patient Handling in Nursing Homes
Marilyn Robertson; Husch Blackwell LLP;
Legal Alert/Article
June 26, 2014, previously published on June 17, 2014
The U.S. Occupational Safety and Health Administration (OSHA) recently published a new brochure titled “Safe Patient Handling: Preventing Musculoskeletal Disorders in Nursing Homes.” In the brochure, OSHA recommends strategies to reduce musculoskeletal disorders (MSDs) in nursing homes....

 

HTMLHRSA “Interprets” Its Enjoined 340 Orphan Drug Rule into Effect
Ellyn L. Sternfield; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.;
Legal Alert/Article
June 23, 2014, previously published on June 18, 2014
In January, I predicted that 2014 would be a game-changer for the 340B Drug Discount Program, in part because of HRSA’s announcement that, in June 2014, it would for the first time publish an omnibus rule governing 340B Program operations.

 

HTMLProtecting Drug Supply Chain Security
Maggie T. Grace, Ralph S. Tyler; Venable LLP;
Legal Alert/Article
June 19, 2014, previously published on June 2014
Millions of Americans take prescription drugs every day while assuming that those drugs are what they purport to be, that they have not been tampered with, and certainly that they are not counterfeit. The validity of those assumptions is increasingly tested and challenged, if not undermined, by a...

 

HTMLIs Evidence of Obviousness Always Required?
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
June 18, 2014, previously published on June 12, 2014
In K/S HIMPP v. Hear-Wear Technologies, LLC, the Federal Circuit affirmed the decision of the Patent Trial and Appeal Board (PTAB) that upheld the decision of the Central Reexamination Unit Examiner that refused to hold claims obvious where the inter partes reexamination requestor had failed to...

 

HTMLFederal Circuit Says Mistaken Belief Required for Reissue Error
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
June 18, 2014, previously published on June 17, 2014
In In re Dinsmore, the Federal Circuit held that the reissue process could not be used to correct an alleged defect in a terminal disclaimer between patents that were not commonly owned, because there had been no “mistaken belief” to support a reissue error within the meaning of the...

 

HTMLSupreme Court Holds That Lanham Act False Advertising Claims Are Not Preempted by FDCA
Andrew Baum; Foley & Lardner LLP;
Legal Alert/Article
June 18, 2014, previously published on June 12, 2014
Earlier today, the U.S. Supreme Court unanimously held that a Lanham Act false advertising case may be brought even if Food and Drug Administration (FDA) beverage labeling regulations permit use of the challenged claim. Reversing the Ninth Circuit, the Court held in POM Wonderful LLC v. The...

 

HTMLPublic Comments on USPTO Proposed Attributable Ownership Rules
Simon J. Elliott; Foley & Lardner LLP;
Legal Alert/Article
June 17, 2014, previously published on May 27, 2014
The USPTO proposed attributable ownership rules would require the public disclosure of the “attributable owner” of patent applications and patents. In this article, I outlined some of my concerns with the proposed rules. Here, I provide a review of some of the written comments submitted...

 

HTMLSupreme Court Adopts Reasonable Certainty Test for Definiteness
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
June 17, 2014, previously published on June 10, 2014
On June 2, 2014, the Supreme Court issued a unanimous decision in Nautilus, Inc. v. Biosig Instruments, Inc., rejecting the Federal Circuit’s “insolubly ambiguous” test for patent claim indefiniteness under 35 USC § 112, and instead adopting a “reasonable certainty...

 

HTMLFederal Circuit Vacates Infringement of Braintree SUPREP Patent
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
June 6, 2014, previously published on May 29, 2014
In a divided opinion issued in Braintree Labs., Inc. v. Novel Labs., Inc., the Federal Circuit reversed the district court on one of two challenged claim construction issues and vacated the district court’s finding of infringement to remand for further factual findings. When no judge agrees...

 

HTMLThe Hare Loses Steam - Patent Litigation Reform Law Unlikely This Year
Ann G. Fort; Sutherland Asbill & Brennan LLP;
Legal Alert/Article
June 6, 2014, previously published on May 23, 2014
Efforts by the U.S. Senate to pass an alternative to the Innovation Act, which aims to reform abusive patent litigation, have stalled. Sen. Patrick Leahy, who is leading the effort, has announced that his committee is tabling that work until the interested parties reach a bipartisan compromise....

 


View Page: <<  Prev  11  12  13  14  15  16  17  18  19  20  Next  >>